Literature DB >> 12900272

Innate sensors for Gram-positive bacteria.

Joerg R Weber1, Philippe Moreillon, Elaine I Tuomanen.   

Abstract

More than half of invasive bacterial infections are Gram-positive in origin. This class of bacteria has neither endotoxins nor an outer membrane, yet it generates some of the most powerful inflammatory responses known in medicine. Some recent seminal studies go a long way toward settling the controversies that surround the process by which Gram-positive bacterial surfaces trigger the human immune system. Although the components of the cell wall are now chemically defined in exquisite detail and the interaction with the toll-like receptor 2 pathway has been discovered, it is only very recently that definitive studies combining these advanced biochemical and cell biological tools have been carried out. It is these breakthrough studies that have finally confirmed the paradigm of innate sensors for Gram-positive bacteria.

Entities:  

Mesh:

Year:  2003        PMID: 12900272     DOI: 10.1016/s0952-7915(03)00078-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  22 in total

1.  Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus.

Authors:  Catrin E Moore; Shelley Segal; Anthony R Berendt; Adrian V S Hill; Nicholas P J Day
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia.

Authors:  Tammy Kielian; Nilufer Esen; Edward D Bearden
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

3.  Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways.

Authors:  Daniela Bermpohl; Annett Halle; Dorette Freyer; Emilie Dagand; Johann S Braun; Ingo Bechmann; Nicolas W J Schröder; Joerg R Weber
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

Review 4.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

5.  Cell wall-mediated neuronal damage in early sepsis.

Authors:  Carlos J Orihuela; Sophie Fillon; S Hope Smith-Sielicki; Karim C El Kasmi; Geli Gao; Konstantinos Soulis; Avinash Patil; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  A Flowthrough Assay for Rapid Bedside Stratification of Bloodstream Bacterial Infection in Critically Ill Patients: a Pilot Study.

Authors:  Pramod Jagtap; Rohini Singh; Karuna Deepika; Venkataraman Sritharan; Shalini Gupta
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

7.  Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess.

Authors:  Tammy Kielian; Nilufer Esen; Shuliang Liu; Nirmal K Phulwani; Mohsin M Syed; Napoleon Phillips; Koren Nishina; Ambrose L Cheung; Joseph D Schwartzman; Jorg J Ruhe
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

8.  Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2009-04-07       Impact factor: 4.030

9.  Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess.

Authors:  Werner Stenzel; Sabine Soltek; Monica Sanchez-Ruiz; Shizuo Akira; Hrvoje Miletic; Dirk Schlüter; Martina Deckert
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

10.  Peptidoglycan recognition protein-SD provides versatility of receptor formation in Drosophila immunity.

Authors:  Lihui Wang; Robert J C Gilbert; Magda L Atilano; Sergio R Filipe; Nicholas J Gay; Petros Ligoxygakis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.